[1] Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. Ca Cancer J Clin, 2015, 65: 87-108.
[2] Bruix J, Reig M, Sherman M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology, 2016, 150: 835-853.
[3] Europea Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J hepatol, 2012, 56: 908-943.
[4] Contratto M, Wu J. Targeted therapy or immunotherapy Optimal treatment in hepatocellular carcinoma. World J Gastrointest Oncol, 2018, 10: 108-114.
[5] Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology, 2018, 67: 358-380. |
